Clinical Trials · NCT00620282
The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 49
- Start date
- Feb 2008
- Locations
- 1 site, United States
- Primary endpoint
- Change in Acetylcholine (ACh)-Mediated Forearm Blood Flow (FBF)